Next Article in Journal
Limited Efficacy of Nanoparticle-Assisted Electroporation for Membrane Permeabilization and Gene Electrotransfer
Previous Article in Journal
The Secretome of Human Deciduous Tooth-Derived Mesenchymal Stem Cells Enhances In Vitro Wound Healing and Modulates Inflammation
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sustainable Olive Pomace Extracts for Skin Barrier Support

by
Roberta Cougo Riéffel
1,
Lucas Agostini
2,
Naira Poener Rodrigues
2,
Simone Jacobus Berlitz
1,
Lígia Damasceno Ferreira Marczak
2 and
Irene Clemes Külkamp-Guerreiro
1,*
1
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Federal do Rio Grande do Sul, Porto Alegre 90610-000, Brazil
2
Programa de Pós-graduação em Engenharia Química, Universidade Federal do Rio Grande do Sul, Porto Alegre 90610-000, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(8), 962; https://doi.org/10.3390/pharmaceutics17080962
Submission received: 24 June 2025 / Revised: 15 July 2025 / Accepted: 22 July 2025 / Published: 25 July 2025

Abstract

Background: Olive pomace, a byproduct of olive oil production, represents approximately 85% of the processed material and poses environmental risks when improperly discarded. Its composition is rich in polyphenols with potential for cosmetic use, especially in skin barrier care. Objective: To develop a natural extract rich in antioxidants from olive pomace using sustainable solvents (water and 1,3-propanediol) for skin barrier support. Methods: The phenolic composition and in vitro biological activities of the extracts were analyzed. Results: The extracts demonstrated a reducing capacity (15 to 33 mg GAE/g) and flavonoid content (4 to 5 mg QE/g). In addition, their antioxidant capacity was proven through the inhibition of the DPPH radical (7% to 91%) and ABTS (7% to 95%) and the reduction in oxidation in the beta-carotene/linoleic acid system (6% to 35%), presenting results superior to those of tocopherol acetate. The hydroxytyrosol and oleuropein compounds, ranging from 28 to 54 and 51 to 85 µg/mL, respectively, were quantified via HPLC. The extract with the highest levels of hydroxytyrosol and oleuropein was analyzed via UHPLC-QqTOF-MS, and 33 compounds were identified. This extract showed antiglycation activity (24% to 40%). The incorporation of this extract into a cosmetic emulsion resulted in sufficient antioxidant capacity to replace tocopherol acetate. Conclusions: The use of effective extraction techniques and nontoxic solvents ensures the sustainability and safety of the extract for application as a natural cosmetic ingredient, aiming to promote the health and integrity of the skin barrier.

Graphical Abstract

1. Introduction

The skin, the outermost layer of the human body, performs essential functions such as regulating temperature, preventing transepidermal water loss (TEWL), controlling permeability to electrolytes and other substances, and participating in the immune and endocrine systems. It also acts as a physical barrier against external aggressors and ultraviolet radiation. The epidermal permeability barrier, which is mainly composed of the stratum corneum (SC), is the primary defense for maintaining hydration, skin homeostasis, and, consequently, the survival of organisms [1,2]. The SC is a multilayered structure formed by anucleated and flattened keratinocytes organized in highly ordered lipid lamellae. Alterations in the SC compromise the integrity of the skin barrier, making the maintenance of SC homeostasis essential for skin health [1].
Constant exposure of the skin to environmental factors such as UV radiation, diet, and pollution stimulates the production of reactive oxygen species (ROS) [3]. These species include free radicals, nonradical species, and reactive nitrogen species (RNS), which interact with proteins, lipids, and DNA, causing cellular and structural damage in the skin matrix [4,5]. Oxidative stress occurs when there is an imbalance between ROS production and the antioxidant system’s capacity to neutralize them [4]. Skin defense against this stress involves antioxidant enzymes such as glutathione, catalase, superoxide dismutase, and peroxidase, as well as nonenzymatic antioxidant molecules [6]. The intrinsic antioxidant system often demonstrates insufficient capacity for the complete neutralization of reactive oxygen species (ROS); consequently, its deficiency necessitates the exogenous administration or topical application of natural antioxidants, such as phenolic compounds [3,6,7]. Strengthening this system can effectively protect the skin barrier, as lipid and protein oxidation compromises its integrity, triggering various pathologies [2,6].
Phenolic compounds directly eliminate or reduce ROS generation by forming relatively stable radicals that interrupt the cellular oxidative chain. Furthermore, they enhance the cellular antioxidant capacity by activating nuclear factor erythroid 2-related factor 2 (Nrf2) [3]. Topical application of polyphenols improves skin barrier function by increasing the expression of structural proteins such as filaggrin, involucrin, and loricrin. TEWL also occurs through the activation of aquaporin 3 (AQP3), which enhances stratum corneum hydration. The antioxidant action of polyphenols contributes to cellular longevity through signaling pathways, including mitogen-activated protein kinase/extracellular signal-regulated kinase (MPK-1/ERK), silent information regulator 2 homolog 1/abnormal Dauer Formation protein 16 (SIR-2.1/DAF-16), and insulin-like growth factor 1 (IGF-1) [8].
Given the potential of polyphenols in skin barrier repair, sustainable sources of these compounds, such as agricultural byproducts, have attracted increasing interest [9]. Olive pomace, a solid waste byproduct of olive oil processing, presents a promising opportunity for the development of innovative and sustainable products. This pomace can be utilized as a raw material for extracting bioactive compounds relevant to the cosmetic sector, thereby contributing to a circular ecosystem of value generation [10,11]. Compared to olive pomace, which accounts for approximately 85% of the total mass from olive production, olive pomace necessitates appropriate disposal to mitigate its potential environmental impacts [12]. The implementation of sustainable management practices for this byproduct can help reduce waste generation while maximizing the economic potential of olive oil production [13,14]. The potential reutilization of olive pomace is largely attributed to its phenolic composition, as approximately 97% of these compounds remain in the pomace [15]. Polyphenol-rich plant extracts, including those derived from olive pomace, hold promise for enhancing skin barrier homeostasis and promoting overall skin health [6]. Several strategies are currently being explored to optimize the recovery and valorization of olive phenolic compounds [12].
Emerging technologies, such as supercritical fluid extraction and pulsed electric field extraction, have been explored; however, their cost-effectiveness may limit their application [16,17]. Conventional extraction techniques use organic solvents, which have several drawbacks related to their flammability, non-degradability, and toxic nature, increasing safety concerns [18]. In this context, solid–liquid extraction techniques utilizing nontoxic solvents have gained increasing recognition for their applicability in various industries. Among these, 1,3-propanediol—a naturally derived solvent obtained through corn fermentation—has emerged as a viable alternative to synthetic and potentially harmful options [19]. Its incorporation into cosmetic formulations represents a significant advancement, offering both efficacy and safety while enhancing the interaction between bioactive compounds and the skin. Additionally, 1,3-propanediol confers physiological benefits, notably reducing TEWL and improving skin hydration, both of which are fundamental to maintaining skin barrier integrity [20,21].
Recent studies have highlighted the rich phenolic composition and multifunctional bioactivity of extracts derived from olive byproducts for cosmetic applications. Cádiz-Gurrea et al. [22] identified 49 phenolic compounds in olive leaf extracts, which demonstrated synergistic antioxidant, anti-inflammatory, photoprotective, and antiaging properties relevant to skin health. Similarly, Kishikawa et al. [23] evaluated extracts from olive oil byproducts, including leaves, stems, flowers, pomace, fruit pulp, and seeds, confirming their biological activity for skin care through effects such as a reduction in melanin biosynthesis, the stimulation of collagen production, and anti-inflammatory responses. Despite the large number of olive-based cosmetic products available on the market, formulations utilizing olive pomace remain scarce. Rodrigues et al. [24] emphasized this gap, highlighting the importance of exploring the phenolic profile and potential applications of olive pomace in cosmetic development.
The valorization of olive residues aligns with the United Nations (UN) Sustainable Development Goals (SDGs), specifically SDG 12, which promotes responsible consumption and production by encouraging prevention, recycling, and reuse to minimize environmental impacts. Additionally, this approach contributes to SDG 9 by fostering innovation and sustainable industrialization, SDG 13 by reducing environmental impacts and mitigating climate change, and SDG 3 by supporting the development of natural ingredients that promote health and well-being [25]. Additionally, consumers increasingly value upcycling in the cosmetics sector, and transforming raw materials that were previously discarded into high-value products enhances the sustainable profile of final formulations. Byproducts, once regarded as waste, are now attracting considerable interest because their composition is rich in bioactive compounds [24].
To address the inherent difficulties of extraction methods utilizing organic solvents, this study aimed to develop a natural and innovative olive pomace extract for topical application. This endeavor involved an effective, simple, economical, and sustainable process for extracting phenolic compounds from the plant matrix, leveraging a natural and skin-compatible solvent in accordance with green chemistry principles. The resulting extracts were comprehensively characterized for their phytochemical composition, in vitro antioxidant capacity, and antiglycation activity. The extract was subsequently integrated into a cosmetic emulsion, revealing the profound implications of such activities for skin health and barrier integrity.

2. Materials and Methods

2.1. Reagents, Chemicals, and Equipment

Reagents and chemicals: Folin–Ciocalteu phenol reagent, oleuropein, hydroxytyrosol, 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS), gallic acid, 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox®), bovine serum albumin, and β-carotene were obtained from Sigma–Aldrich, (St. Louis, MO, USA) Potassium persulfate and fructose were obtained from Synth (Diadema, Brazil). Ethanol and methanol were obtained from Exôdo Científica (Sumaré, Brazil). Linoleic acid, acetonitrile, and glacial acetic acid were obtained from Vetec (Duque de Caxias, Brazil). Tween 20 was obtained from Dinâmica (Indaiatuba, Brazil). Cloroform, carnosine, and tocopheryl acetate were obtained from Neon (Suzano, Brazil), Chemyunion (Sorocaba, Brazil) and Basf (Ludwigshafen, Germany), respectively.
Equipment: UV–VIS spectrophotometer T 80+, PG Instruments Limited (Leicester, UK); microplate reader SpectraMax® M5 Series Multi-Mode Microplate Readers, Molecular Devices LLC (São José, CA, USA); UHPLC-QqTOF-MS Impact II Bruker Daltonics Inc. (Billerica, MA, USA); and HPLC Shimadzu CBM-20A System (Shimadzu Europa GmbH, Duisburg, Germany).

2.2. Olive Pomace Collection

The olive pomace from the 2022 harvest (Arbequina, Arbosana, Picual, and Koroneike cultivars) was collected from an agroindustry located in the Campanha Region, Rio Grande do Sul, Brazil. Olive pomace was obtained from the two-phase centrifugation system immediately after olive oil extraction.

2.3. Olive Pomace Extraction Process

The samples were dried in a forced-air oven at a temperature of 55 °C (parameter defined in previous analyses). After drying, the samples were ground in a knife mill and homogenized into particles (≤400 µm). The solid–liquid extraction method was employed for 20 min under continuous stirring at 55 °C. Different solvents and solid/liquid ratios were investigated to prepare three different olive pomace extracts. Olive pomace extract 1 (OPE1) was prepared with water as the solvent and a 1:15 (w/v) solid/liquid ratio. Olive pomace extract 2 (OPE2) was developed with 1,3-propanediol/water (50:50, v/v) as the solvent and a 1:15 (w/v) solid/liquid ratio. Olive pomace extract 3 (OPE3) was prepared with 1.3-propanediol and a 1:10 (w/v) solid/liquid ratio. The olive pomace extracts were subsequently vacuum-filtered.

2.4. Reducing Capacity of the Folin–Ciocalteu Reagent

The reducing capacity of the Folin–Ciocalteu reagent was determined on the basis of the methodology described by Waterhouse [26]. Briefly, a gallic acid concentration curve (10 to 90 mg/L) was constructed (R2 = 0.9937). The results are expressed in milligrams of gallic acid per gram of dried olive pomace (mg GAE/g). The reaction mixture consisted of 850 μL of distilled water, 200 μL of sample, and 100 μL of Folin–Ciocalteu reagent. The mixture was vortexed, and 850 μL of 7% sodium carbonate was added. The solution was kept in the dark for 1 h. The absorbance was measured at 765 nm with a UV–VIS spectrophotometer.

2.5. Total Flavonoid Content

The total flavonoid content methodology was based on the technique described by Chang et al. [27]. The samples (0.5 mL) were mixed with 1.5 mL of water and 0.1 mL of 10% aluminum trichloride (AlCl). Then, 0.1 mL of 1 M potassium citrate and 2.8 mL of distilled water were added. The samples were incubated for 30 min in the dark, and the absorbance was measured at 415 nm via a UV–VIS spectrophotometer. A blank control was prepared in the same way without the addition of the sample or aluminum chloride. A quercetin concentration curve was prepared (R2 = 0.9955). The results are expressed as milligrams of QE per gram of dried olive pomace (mg QE/g).

2.6. Deactivation of the 2,2′-Azinobis-3-Ethylbenzothiazoline-6-Sulfonic Acid (ABTS) Radical

The ABTS radical deactivation methodology was adapted from the protocol of Re et al. [28]. For the formation of the ABTS radical, 5 mL of 14 mM ABTS solution was mixed with 5 mL of 4.9 mM potassium persulfate and kept at room temperature, protected from light, for 16 h. For the reaction system, 0.3 mL of ABTS was added to 30 mL of ethanol. The absorbance was measured at 750 nm in a UV–VIS spectrophotometer. Ethanol was used as a blank. Initially, 1.8 mL of the working ABTS solution was analyzed in spectrophotometric mode. Then, 0.2 mL of the test mixture was added, and the mixtures were homogenized and kept in the dark for 60 min. The absorbances were measured in spectrophotometric mode. Different concentrations of OPE1, OPE2, and OPE3 were evaluated (5, 7.5, and 10 mg/mL were diluted in ethanol). The natural antioxidant tocopheryl acetate and the synthetic antioxidant butylated hydroxytoluene (BHT) were analyzed for comparison. The percentage of inhibition was calculated via Equation (1):
% i n h i b i t i o n = ( ( A b s . i n i t i a l A b s . f i n a l ) / A b s . i n i t i a l ) × 100
where Abs.initial is the absorbance of the radical before the addition of the sample and Abs.final is the absorbance of the radical after analysis in kinetic mode. The results are expressed as percentages of ABTS inhibition and as IC50 values, which were defined as the antioxidant concentration required to reduce the absorbance of the control by 50%.

2.7. Antioxidant Capacity Determination via DPPH Radical Analysis

The determination of antioxidant activity via the DPPH radical assay followed the methodology described by Gonzales et al. [29]. Three different concentrations (0.25 to 100 mg/mL) of OPE1, OPE2, and OPE3 were evaluated. The natural antioxidant tocopheryl acetate (0.25 to 100 mg/mL) and the synthetic antioxidant butylated hydroxytoluene (BHT) (0.05 to 1.00 mg/mL) were analyzed for comparison. The results are expressed as percentages of DPPH inhibition (5, 7.5, and 10 mg/mL concentrations) and as IC50 values, which were defined as the antioxidant concentration required to reduce the absorbance of the control by 50%. A 20 μg/mL DPPH solution was prepared in methanol. For the reactions, 3 mL of the DPPH reagent was mixed with 1 mL of the sample or with methanol as a negative control. The mixtures were homogenized and kept in the dark for 2 h. The absorbances were measured at 515 nm via a UV–VIS spectrophotometer. The percentage of inhibition was calculated via Equation (2):
% D e a c t i v a t i o n = A c A s A c × 100
where Ac is the absorbance of the control and As is the absorbance of the sample.

2.8. Antioxidant Capacity of the Beta-Carotene/Linoleic Acid System

The antioxidant capacity of the beta-carotene/linoleic acid system followed the methodology described by Paim et al. [30]. A reaction mixture containing 60 mg of linoleic acid, 600 mg of Tween 20, and 6 mg of beta-carotene was prepared. Chloroform (30 mL) was used for beta-carotene solubilization, and it was removed via rotary evaporation (Fisaton Rotary Evaporator, Model 450, Brazil). Subsequently, approximately 150 mL of distilled water saturated with oxygen was added to the mixture under constant stirring. Dilutions were made at concentrations of the extracts of 1.0 and 2.0 mg/mL. Tocopheryl acetate was used as a positive control. Beta-carotene/linoleic acid solution (2.5 mL) was added to 0.2 mL of each sample. The absorbance was measured via a UV–VIS spectrophotometer at 470 nm immediately after sample preparation. The tubes were kept in a water bath at 50 °C and exposed to light. The second reading was performed after 120 min. The results are expressed as the percentage of inhibition of beta-carotene oxidation. The decrease in the absorbance of the samples was used to determine the percentage of oxidation of the olive pomace extracts via Equation (3):
% O x i d a t i o n   i n h i b i t i o n = [ 1 ( A b s . i n i A b s / A b s . c o n t . i n i A b s . c o n t . ) ] × 100
where Abs.ini is the absorbance of the sample at the initial reaction time, Abs. represents the absorbance of the sample after 120 min, Abs.cont.ini. is the absorbance of the negative control at the initial time, and Abs. cont. is the absorbance of the negative control after 120 min.

2.9. Stability Study

The stability of the olive pomace extracts was analyzed following the methodology described by Kesente et al. [31]. The samples were stored under different conditions: refrigerated (5 °C), at room temperature (25 °C), and in a climate chamber (40 °C). The samples were analyzed at 0, 30, 60, and 90 days for their Folin–Ciocalteu reducing capacity (described in Section 2.4).

2.10. Simultaneous Determination of Hydroxytyrosol and Oleuropein via HPLC

OPE1, OPE2, and OPE3 were analyzed as described by Habibi et al. [32], using a Shimadzu CBM-20A System equipped with an SIL-20AC automatic sampler, a CTO-20AC column oven, and an SPD-20AV UV/VIS detector. The data were acquired and analyzed via LC-Solution software. The column used was a Synergi Hydro-RP C18 4 μm, 250 × 4.6 mm, coupled to an ODS-C18 precolumn, 5 μm, 4 × 3 mm (Phenomenex, California, USA). The mobile phase was water with glacial acetic acid (0.5%) (eluent A) and acetonitrile (eluent B). The elution gradient used was 5–20% B (0–30 min), 20–30% B (30–40 min), and 30–35% B (40–45 min), with a flow rate of 1 mL.min−1. The column temperature was maintained at 25 °C, and the injection volume was 20 μL. The OPE2 and OPE3 samples were diluted 5-fold in ultrapure water, and OPE1 was not diluted. The detection wavelength was 280 nm. An analytical curve of hydroxytyrosol and oleuropein was constructed (R2= 0.9999).

2.11. Qualitative Analysis Via Ultrahigh-Efficiency Liquid Chromatography Coupled with Ultrahigh-Resolution Mass Spectrometry (QTOF) (UHPLC-QqTOF-MS)

The methodology was based on the technique described by Peralbo-Molina et al. [33]. The OPE3 extract was selected for evaluation via UHPLC-QqTOF-MS. The sample was prepared by 10-fold dilution in ultrapure water, followed by a filtration step (0.22 μm). For the analysis, a volume of 10 μL of the sample was injected at a flow rate of 0.35 mL/min. The mobile phase used was a 0.1% (v/v) aqueous solution of formic acid (phase A) and pure acetonitrile (phase B). The analyte separation was carried out via a Kinetex 1.7 µm EVO C18 A column (100 × 42.1 mm internal diameter, 5 µm particle size; Phenomenex, California, USA) in the temperature range of 40–60 °C. The gradient method was as follows: 95% A (4 min), 2% A (35 min), 2% A (40 min), 95% A (44 min), and 0% A (50 min). The dual ESI source was operated in negative ionization mode with the following conditions: nebulizer gas at 4.0 bar and the flow rate and drying gas temperature at 9.0 L/min and 200 °C, respectively. The capillary voltage was set at 2500 V, and the end plate offset was adjusted to 500 V. The bbCID (MS-MS/MS) scanning mode was used, and the collision energies were set to scan automatically from 20 to 60 eV. The full scan was performed at a rate of one spectrum per second within the range of 50 to 1500 m/z. Data analysis and processing were carried out via Data Analyses software (Bruker Daltoniks, MA, USA). The precision limit for elemental composition confirmation was set at 5 ppm. To confirm the presence of compounds in the extract, mSigma data, the MassBank Data Platform (https://massbank.eu/MassBank/search, accessed in January 2022 and January–February 2023), and information from the scientific literature were used, considering parameters such as fragment ions, molecular formula, and molecular mass.

2.12. Antiglycation Activity

OPE3 antiglycation activity was evaluated via the BSA–fructose model [34]. Reaction solutions of fructose (1.5 mol/L), bovine serum albumin (BSA) (60 mg/mL), and carnosine (150 µg/mL) were prepared in potassium phosphate buffer (0.2 mol/L, pH 7.4) containing 0.06% sodium azide. The test solution was prepared by diluting 0.2 and 3.5 mg/mL OPE3 extract in the same buffer. A total of 500 μL of the fructose solution was incubated with 500 μL of the test sample solution at 37 °C. After 2 h, 500 μL of the BSA solution was added, and the fluorescence was measured at time zero. The samples were returned to the incubator at 37 °C for 7 days. The fluorometric assays were performed with a microplate reader at an emission wavelength of 450 nm with excitation at 340 nm. A negative control was prepared using phosphate buffer, fructose, and BSA. The glycation inhibition percentage was calculated via Equation (4):
% I n h i b i t i o n = 1 ( F i 7 d   s a m p l e F i 0 d   s a m p l e ( F i 7 d   n e g   c o n t F i 0 d   n e g   c o n t ) ) × 100
where Fi0d and Fi7d represent the fluorescence intensity at time zero and after 7 days of reaction, respectively; and neg cont refers to the negative control.

2.13. Antioxidant Capacity of Cosmetic Formulations

The OPE3 extract was selected for incorporation into a cosmetic emulsion prepared via the phase inversion method [35]. Table 1 presents the qualitative and quantitative compositions of the emulsions and the respective functions of each component. OPE3 (1% w/w) was incorporated as the active ingredient; and a control formulation was prepared in which the extract was replaced with tocopheryl acetate (1% w/w) for comparison. The pH of the formulations was adjusted to 5 with citric acid. The antioxidant activities of the cosmetic formulations were analyzed via the DPPH radical scavenging method, as described in Section 2.8. The cosmetic formulation without the active ingredients was also evaluated for comparison.

2.14. Statistical Analysis

Statistical analyses were performed via ANOVA followed by Tukey’s or Dunnett’s test in GraphPad Prism version 5.0 software. The data are expressed as the means ± standard deviations. A p value of <0.05 was considered statistically significant. All tests were performed in triplicate.

3. Results and Discussion

3.1. Olive Pomace Extraction

Table 2 presents the reducing capacity of the Folin–Ciocalteu reagent and the total flavonoid content.
The extraction of olive pomace was developed by applying the following green chemistry principles: safer solvents, design for economic efficiency, and the use of renewable raw materials [36,37]. Water and 1,3-propanediol were used as environmentally friendly solvents (as an alternative to harmful organic solvents).
Extracts using 1,3-propanediol (OPE2 and OPE3) showed greater reducing capacities than the aqueous extract (OPE1), highlighting its potential as a green solvent for extracting valuable compounds from olive pomace. This result reinforces the importance of selecting extraction conditions that combine efficiency and sustainability. Indeed, overcoming the limitations of conventional extraction processes requires the use of innovative solvents that are environmentally sustainable, less toxic, economically viable, and more selective. Additionally, factors such as the plant matrix characteristics, solubility, molecular structure, and chemical nature of bioactive compounds must be carefully considered to ensure maximum extraction efficiency [38]. The reducing capacity observed for the aqueous extract (OPE1) aligns with values reported in the literature for similar extraction methods. For example, Goldsmith et al. [37] obtained reducing capacities of 13.76 ± 0.91 mg GAE/g and 19.71 ± 1.41 mg GAE/g via conventional and ultrasound-assisted water extraction, respectively. Other solvents have also been explored: Almeida Pontes et al. [39] achieved a relatively high reducing capacity of 25.32 mg ± 0.35 GAE/g using a 50:50 ethanol/water mixture. Furthermore, Chanioti and Tzia [40] investigated green solvents such as natural deep eutectic solvents (NADESs) and reported reducing capacities ranging from 13 to 34 mg GAE/g.
According to Chang et al. [27], the aluminum chloride colorimetric method, which is specific for flavonols and flavones, could underestimate the content of other classes of flavonoids in samples with many compounds. This limitation may explain the low total flavonoid contents presented in Table 2. The results for total flavonoid content followed a similar pattern to those observed for reducing capacity. Compared to the aqueous extract, the extracts prepared with 1,3-propanediol as the solvent presented a significantly greater content of total flavonoids. Furthermore, the extract produced solely with 1,3-propanediol presented the highest flavonoid content among all the extracts analyzed.
Overall, the results of this investigation clearly demonstrate the efficacy of the proposed sustainable extraction process for obtaining bioactive compounds from olive pomace. In particular, the use of 1,3-propanediol as a solvent was highly effective, yielding extracts with superior antioxidant properties. Thus, these extracts are promising alternatives for skin care, especially for maintaining skin barrier homeostasis, since, according to Butkeviciute et al. [5], plant-based phenolic compounds demonstrate, in addition to their antioxidant capacity and low toxicity, excellent skin permeability properties.

3.2. ABTS and DPPH Radical Analysis of the Antioxidant Capacity

The antioxidant capacity of olive pomace extracts (OPE1, OPE2, and OPE3) was evaluated via the inhibition of ABTS (Figure 1) and DPPH (Figure 2) radicals via colorimetric, indirect, and electron transfer-based methods. To evaluate the antioxidant efficacy of the samples, it is crucial to employ complementary assays to ensure a comprehensive evaluation [41]. The structure of phenolic compounds is a determining factor in their radical inhibition activity; the hydroxyls that make up phenolic compounds act as electron donors, allowing the neutralization of reactive oxygen species and the formation of radicals via a mesomeric effect [42]. The olive pomace extracts were analyzed and compared with tocopheryl acetate at different concentrations. Tocopheryl acetate was chosen because it is an antioxidant which is widely used in cosmetics and food [43].
With respect to the ABTS radical scavenging activity, both extracts with 1,3-propanediol showed greater activity against the radical than the aqueous extract. Among all the extracts analyzed, the one obtained using 1,3-propanediol alone (OPE3) presented the highest ABTS deactivation activity, even compared to tocopherol acetate, at all the concentrations tested. These comparisons highlight the potential of the extraction method employed in this study to yield olive pomace extracts with enhanced antioxidant properties. Karaosmaglu et al. [44] examined methanolic extracts of olive oil rich in phenolic compounds and reported between 1.31% and 21.97% ABTS free radical scavenging activity, demonstrating the effectiveness of the extraction method used herein in the recovery of antioxidant bioactive compounds.
The concentration of an antioxidant agent required to decrease the initial absorbance of ABTS by 50% (IC50) is a widely used parameter to represent the activity of antioxidants. Table 3 shows the results of this analysis and the comparison of OPE1, OPE2, OPE3, tocopheryl acetate, and BHT.
Compared to tocopherol acetate, olive pomace extracts demonstrated a greater capacity to inhibit ABTS. Among the extracts, the same trend was observed for the reduction in the Folin–Ciocalteu and total flavonoids, with an emphasis on the extracts produced with 1,3-propanediol. These results prove the potential for the application of olive pomace extracts as natural antioxidants.
The percentage of inhibition of the DPPH radical was analyzed, and the results are shown in Figure 2.
As expected, the DPPH radical inhibition capacity was concentration-dependent for all the samples tested, as were the results of the ABTS inhibition assay. However, the inhibition values were greater, demonstrating the greater effectiveness of the samples against this radical. The aqueous extract (OPE1) demonstrated a DPPH inhibition capacity similar to that of tocopheryl acetate across all the tested concentrations. Moreover, the 1,3-propanediol extracts (OPE2 and OPE3) consistently demonstrated greater DPPH radical scavenging activity than both the aqueous extract and tocopherol acetate. At a concentration of 7.5 mg/mL, OPE3 presented a greater DPPH inhibition capacity than OPE2 did, whereas at concentrations of 5 and 10 mg/mL, both extracts, OPE2 and OPE3, presented the same DPPH inhibition capacity.
Table 4 presents the DPPH radical inhibition capacity expressed as the IC50 values (the concentration of antioxidant required to reduce the absorbance by 50%). On the basis of these previous results, OPE3 was chosen for comparison with BHT and tocopheryl acetate. OPE3 presented an intermediate IC50 value, with better antioxidant activity than tocopheryl acetate. Overall, these results showed that olive pomace extracts could be used to replace tocopheryl acetate as an antioxidant in formulations.
The cosmetic and dermatological interest in phenolic compounds derived from plants is based mainly on their antioxidant capacity, and their topical application minimizes oxidative damage to the skin, in addition to providing photoprotective activity and assisting in providing therapy for the skin barrier [5,42].

3.3. Antioxidant Capacity of the Beta-Carotene/Linoleic Acid System

The ability of olive pomace extracts to inhibit beta-carotene oxidation was evaluated at two different concentrations (1 and 2 mg/mL). The results are presented in Figure 3.
Compared to other olive pomace extracts, OPE3 significantly differed in its ability to inhibit oxidation and has the same antioxidant capacity as tocopheryl acetate at both concentrations tested. The ability to protect β-carotene bleaching from degradation generated by the linoleic acid oxidation products found in this study agrees with the values demonstrated in the literature, such as the findings of Karaosmaglu et al. [44], who examined methanolic extracts of olive oil rich in phenolic compounds and reported that the antioxidant capacity of the beta-carotene/linoleic acid system ranged from 21 to 64%. A commercial olive extract for topical use reduced skin lipid peroxidation by 27% after sun exposure [42].
Tocopheryl acetate was used as the reference standard in this assay because beta-carotene can inhibit singlet oxygen and interact with tocopheryl acetate to prevent lipid peroxidation, making it the appropriate control in this assay [45]. Notably, the antioxidant performance of OPE3 was comparable to that of tocopheryl acetate, highlighting its potential as a natural alternative with similar efficacy.

3.4. Stability Studies

The reducing capacity of the Folin–Ciocalteu reagent was employed to assess the stability of the OPE1, OPE2, and OPE3 extracts, and the results are depicted in Figure 4.
Stability testing of the aqueous extract (OPE1) was limited to 30 days due to microbial growth, which occurred after 15 days for samples stored at room temperature. During the storage period, OPE2 showed evident variations in the analyses, especially on the 60th day, under refrigerated and climate chamber conditions. This may be explained by oxidation/reduction reactions that can modify phenolic compounds, potentially leading to the formation of new phenolic compounds or the transformation of precursors into more active compounds and other derivatives [31]. Furthermore, the Folin–Ciocalteu reduction method presents technical limitations, as the reagents used in the spectrophotometric analysis react with all the reactive hydroxyl groups present in the matrix, not exclusively with polyphenols [46]. After 90 days, OPE2 presented a maximum reduction of 18% in reducing capacity. Conversely, the OPE3 extract only significantly reduced the reducing capacity under the most severe storage conditions (climatic chamber) and after 90 days. However, this reduction was only 8%. These findings indicate that the use of 1,3-propanediol, in addition to being a more suitable extraction solvent, also contributes to the stability of the system. Indeed, previous studies have reported the antimicrobial activity of 1,3-propanediol [47].

3.5. Simultaneous Determination of Hydroxytyrosol and Oleuropein via HPLC-DAD

OPE1, OPE2, and OPE3 extracts were analyzed by HPLC-DAD for the simultaneous determination of hydroxytyrosol (HT) and oleuropein (OLE) (Figure 5). Hydroxytyrosol and oleuropein are compounds generally found in olives and their derivatives, and olive pomace is an important source of hydroxytyrosol [24]. These compounds exhibit numerous beneficial biological activities, attracting interest from the cosmetic and pharmaceutical industries [43]. Both phenolic compounds were identified and quantified in the olive pomace extracts, with there being a higher concentration of oleuropein than of hydroxytyrosol in all the samples tested.
Hydroxytyrosol, a phenolic alcohol, is a product of oleuropein hydrolysis and possesses significant antioxidant properties, surpassing those of other phenolic compounds and natural antioxidants such as vitamin C, as well as synthetic antioxidants such as butylated hydroxytoluene (BHT). In the skin, it has important activities, including anti-inflammatory and photoprotective effects, and acts as an inhibitor of tyrosinase and senescence-associated β-galactosidase [24]. Hydroxytyrosol enhances the proliferation of keratinocytes, indicating its involvement in repair, regeneration, and epithelial differentiation mechanisms, as evidenced by a significant increase in the expression of Ki67 (Ki-67 antigen). Furthermore, it reduces inflammation in the human epidermis by preventing the secretion of inflammatory cytokines (IL-1 and IL-8), lowering NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) levels, and inhibiting inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Hydroxytyrosol also has photoprotective effects by reducing the protein damage caused by UVA radiation and UVB-induced genotoxicity. Thus, it contributes to the maintenance of the epidermal barrier [24,42,48].
Among the biological activities of oleuropein, its antioxidant capacity and ability to chelate metal ions such as copper (Cu) and iron (Fe) stand out, preventing these ions from generating free radicals and scavenging superoxide anions [49]. Oleuropein exerts beneficial effects on the skin barrier by modulating various cellular and molecular processes. Owing to the presence of an ortho-diphenolic group in its structure, oleuropein can eliminate ROS through hydrogen donation and stabilize oxygen radicals via intramolecular hydrogen bonding [50]. In addition, oleuropein stimulates the synthesis of antioxidant enzymes via the NRF2 pathway and promotes epidermal cell proliferation while efficiently inhibiting TEWL [42]. According to Asghariazar et al. [51], this phenolic molecule influences the expression of caspases 3 and 9, promoting the regulation of apoptosis and cell renewal, which are essential for epidermal homeostasis. Furthermore, it reduces the expression of NF-κB, contributing to the attenuation of local inflammation. The regulation of peroxisome proliferator-activated receptor gamma (PPAR-γ) by oleuropein supports the maintenance of the lipid function of the skin barrier, whereas the modulation of interferon gamma (IFN-γ), a cytokine produced by resident T lymphocytes in the epidermis, assists in the mediation of cutaneous immune responses.

3.6. Qualitative Analysis by UHPLC-QqTOF-MS

OPE3 was analyzed via UHPLC-QqTOF-MS, and a total of 33 compounds were found via their fragment ions and isotopic profile (Table 5). The data included information on the theoretical and experimental m/z values, Milisigma (mSigma) values, retention times of the compounds, and characteristic fragment ions.
The compounds identified had mSigma values ranging from 1.8 to 34.6, corresponding to oleoside and dihydrooleuropein, respectively. The Milisigma (mSigma) value is a numerical value that indicates how similar the theoretical and measured isotopic patterns are, representing the profile of isotopic similarity. A low mSigma value indicates that the isotopic pattern found in the peak is very similar to the theoretical isotopic pattern for the proposed molecular formula. The tolerance for the mSigma value is typically set at 50 [52]. The errors associated with the analysis were consistently low for all the detected compounds, confirming their presence in the OPE3 extract. These compounds are classified into different categories and include simple phenols, iridoid precursors, secoiridoids, flavonoids, lignans, and others.
The simple phenols identified in the OPE3 extract were hydroxytyrosol, tyrosol, dihydroxytyrosol, tyrosol glucoside, and hydroxytyrosol glucoside; these compounds are responsible for the biological activities of olive plant derivatives [52]. The hydroxytyrosol glucoside generates representative fragments [53], one of which corresponds to hydroxytyrosol. The chromatographic signal attributed to hydroxytyrosol glucoside, followed by the signal of dihydroxytyrosol, was more intense than the signal of hydroxytyrosol, as reported by Peralbo-Molina et al. [33]. The mass profile of hydroxytyrosol confirmed the compatibility between the theoretical and experimental data, which was supported by the low mSigma values (Figure 6). Hydroxytyrosol was detected with a precursor ion at m/z 153.0557, which generated fragment ions at m/z 123.0405, 105.0339, and 135.0451. Klen et al. [54] reported fragment ion 123 for hydroxytyrosol. Cádiz-Gurrea et al. [22] reported fragment ions at m/z 123 and 135 for hydroxytyrosol in an olive pomace extract. D’Antuono et al. [55] reported a fragment of m/z 123 for hydroxytyrosol.
Iridoid is a term used to designate numerous groups of monoterpenes and glycoside derivatives, the precursor of which is mevalonic acid [33]. Several iridoid precursors were presented in the OPE3 analysis; these compounds are widely described as constituents of olive extracts and their derivatives. The compounds found were loganin, secologanin, loganic acid, oleoside, oleoside dimethyl ester, oleoside glycoside, oleoside riboside, and oleoside-11-methyl ester [54]. Iridoids are bioactive compounds widely used to treat skin disorders because of their anti-inflammatory and antioxidant properties [22]. Oleoside was found with a precursor ion at m/z 389.1089 and fragment ions at m/z 121.0660, 101.0243, 209.0477, and 345.1253. Klen et al. [54], when analyzing an olive byproduct extract, reported fragments at m/z 345 and 209 for oleoside, and Serrano-Garcia et al. [53] reported a fragment at m/z 345.1180 (Figure 7).
Phenolics classified as secoiridoids are characterized by the presence of the antioxidant oleic acid or its derivatives [33]. Secoiridoids are phenolic compounds unique to Oleaceae plants [56]. Several secoiridoids, including comselogoside, secologanoside, caffeoyl-6′-secologanoside, oleuropein, ligstroside (p-HPEA-EA), and verbascoside, have been identified. Oleuropein derivatives, such as decarboxymethylated glycones, known as oleacein or 3,4-DHPEA-EDA; oleuropein aglycones [57]; dihydrooleuropein [58]; oleuropein derivative 2; and 10-hydroxyoleuropein [33], were also detected in OPE3. Oleuropein was detected with a precursor ion at m/z 539.1770. The fragmentation of this ion resulted in fragments with m/z 377.1306 due to hexose unit cleavage, and 307.0874 and 275.0962, characteristic of the oleuropein structure (Figure 8).
The flavonoids identified in OPE3 include luteolin, rutin, taxifolin, luteolin glucoside, and apigenin glucoside. Rutin was detected at m/z 609.1461, which displayed a fragment ion at m/z 300.0274 resulting from the loss of the glycoside and rhamnoside groups, along with another fragment at m/z 197.0000. Luteolin glucoside, detected at 6.2 min with m/z 447.0933, yielded a fragment ion at m/z 285.0423 due to the loss of a hexose unit. Taxifolin, also known as dihydroquercetin, was also detected, which agreed with the findings of Cádiz-Gurrea et al. [22].
Other simple phenols, such as vanillin or vanillic acid, which are isomers of coumaric acid, have also been found in OPE3 extracts. Similarly, benzyl primeveroside was identified as a precursor of the aroma, as reported by Cádiz-Gurrea et al. [22]. Lignans such as pinoresinol and acetoxypinoresinol, which are recognized for their antioxidant and antitumor properties, have also been found [59,60].
Olive pomace extracts offer a variety of interesting cosmetic bioactives and, consequently, synergistic effects, as interactions among phenolics or between phenolics and other antioxidants can increase their activity. For example, a study by Cádiz-Gurrea et al. [22], who analyzed polyphenol-rich extracts from olive oil byproducts for cosmetic applications, identified numerous phenolic compounds, indicating diverse and multifunctional compositions. The synergistic activity of these compounds is considered responsible for their beneficial effects on the skin, including their antioxidant and anti-inflammatory actions; the inhibition of degenerative enzymes; their photoprotective activity; the reduction in melanin biosynthesis; their antiaging properties; and their therapeutic potential for conditions such as psoriasis, allergic dermatitis, seborrhea, and microbial infections. Carrara et al. [42] conducted a study using hydroxytyrosol- and oleuropein-rich extracts, which demonstrated accelerated cell restoration, increased levels of growth factors, and a two-fold increase in epithelial cell proliferation. The study also revealed that the individual compounds were less effective when tested separately, suggesting that phenolic compounds exhibit greater activity when administered as a complex extract rather than in their purified form.
Moreover, the use of natural and safe solvents, such as 1,3-propanediol, aligns with the principles of green chemistry and contributes to both the effectiveness and overall sustainability of cosmetic products.
Further information on the phenolic composition of OPE3 is available in the Supplementary Material.

3.7. Antiglycation Activity

Glycation is a nonenzymatic reaction in which reducing sugars bind to primary or secondary amino groups, leading to the formation of advanced glycation end products [61]. This process, involving free radicals and carbonyl intermediates, occurs naturally during aging and is related to various pathological processes [62]. The antiglycation activity of OPE3 was analyzed at two different concentrations (2 and 3.5 mg/mL). As shown in Table 6, the antiglycation effect was dose dependent and may have been related to the presence of phenolic compounds in the extract.
For comparison, a positive control containing carnosine (0.3 mg/mL), a well-known antiglycation compound, was selected and tested at a concentration recommended for cosmetic use. Ramkissoon et al. [63] confirmed the correlation between the antioxidant activity, total phenolic content, and antiglycation capacity of medicinal herb extracts. Márquez et al. [61] developed an olive leaf extract with strong antiglycation effects. Kabach et al. [64] reported significant antiglycation activity in methanolic olive extracts, with 60.2% inhibition of advanced glycation end products at a concentration of 60 µg/mL. The accumulation of AGEs in the skin is a remarkable cause of aging: manifestations of AGE-induced skin aging include wrinkles, skin discoloration, reduced radiance, and impaired skin barrier function. In this way, avoiding AGEs can contribute to the health of the skin barrier [65].

3.8. Antioxidant Capacity of Cosmetic Formulations

Antioxidants are suitable ingredients for use in cosmetic formulations, not only because of their ability to inhibit and stabilize free radicals but also because of their potential to protect against photodamage and antiaging effects [12]. Cosmetic formulations containing OPE (FOPE3), tocopheryl acetate, and vehicle were analyzed for their antioxidant potential via the DPPH radical inhibition method (Figure 9).
The formulation containing OPE3 (FOPE3) demonstrated the highest degree of radical inhibition, significantly surpassing that of tocopheryl acetate and the vehicle. Considering that tocopheryl acetate is a widely used antioxidant in the cosmetic industry [66], these results confirm the potential of olive pomace extract as an antioxidant in cosmetic formulations.

4. Conclusions

This study successfully developed a sustainable and efficient extraction process for olive pomace, utilizing simple techniques and the natural solvent 1,3-propanediol. This solvent demonstrated superior performance in extracting phenolic compounds, resulting in an extract rich in these valuable phytochemicals. A total of 33 phenolic compounds were identified, with oleuropein and hydroxytyrosol being particularly prominent.
The resulting extracts exhibited remarkable in vitro antioxidant capacity, effectively inhibited ABTS and DPPH radicals, and demonstrated protective effects within the beta-carotene/linoleic acid system. Furthermore, the extract obtained with 1,3-propanediol maintained its reducing capacity for 90 days and displayed significant antiglycation activity. Notably, its antioxidant capacity surpassed that of tocopheryl acetate, both in its pure form and when incorporated into a cosmetic emulsion. This superior performance suggests its strong potential as a natural ingredient for cosmetic applications. Given that oxidative stress directly compromises skin barrier function, this enhanced antioxidant capacity implies that the extract has the potential to indirectly contribute to skin barrier homeostasis by mitigating oxidative damage to its structural components.
In summary, this research highlights the sustainable and viable repurposing of olive pomace as a renewable source of natural raw material for the cosmetics sector. The high antioxidant capacity of the obtained extract makes it a promising alternative to widely used cosmetic ingredients such as tocopherol acetate. The implementation of effective extraction techniques, combined with the use of a natural and nontoxic solvent, ensures both the sustainability of the production process and the safety of the resulting ingredients. Moreover, the favorable physicochemical properties of the extracts facilitate their direct integration into topical formulations, thereby accelerating their technological transfer for commercial applications. Furthermore, the efficiency of the extraction process and the high availability of olive pomace as a raw material support the feasibility of scaling up this method for industrial production. These qualities establish the extract as a promising candidate for commercial development in the cosmetics industry.
The forthcoming research will advance the practical application of olive pomace extract by thoroughly assessing its safety, including its cytotoxicity and biological performance. These steps are crucial for ensuring the successful and safe application of the extracts in skincare products. Subsequently, clinical trials are essential to confirm the extract biocompatibility and in vivo efficacy of the extract.

5. Patents

The process of extracting antioxidant bioactive compounds from olive pomace has a patent application for invention with the National Institute for Intellectual Protection (INPI) under process number BR 20240036697.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/pharmaceutics17080962/s1, Figure S1: (A) MS/MS spectra of hydroxytyrosol glucoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S2: (A) MS/MS spectra of tyrosol and (B) its fragment ions; (C) theoretical and experimental isotopic profiles, Figure S3: (A) MS/MS spectra of tyrosol glucoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S4: (A) MS/MS spectra of oleoside 11-methylester and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S5: (A) MS/MS spectra of the oleoside dimethylester and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S6: (A) MS/MS spectra of oleoside glucoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S7: (A) MS/MS spectra of oleoside riboside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S8: (A) MS/MS spectra of loganin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S9: (A) MS/MS spectra of loganic acid and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S10: (A) MS/MS spectra of secologanin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S11: (A) MS/MS spectra of comselogoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S12: (A) MS/MS spectra of dihydroxityrosol and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S13: (A) MS/MS spectra of secologonoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S14: (A) MS/MS spectra of caffeoyl-6′-secologanoside and its fragment ions; (B) theoretical and experimental isotopic profile, Figure S15: (A) MS/MS spectra of oleuropein aglycone and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S16: (A) MS/MS spectra of dihydrooleuropein and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S17: (A) MS/MS spectra of the oleuropein derivative and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S18: (A) MS/MS spectra of 10-hydroxy-oleuropein and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S19: (A) MS/MS spectra of p-HPEA-EA and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S20: (A) MS/MS spectra of oleacein and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S21: (A) MS/MS spectra of verbascoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S22: (A) MS/MS spectra of luteolin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S23: (A) MS/MS spectra of luteolin glucoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S24: (A) MS/MS spectra of rutin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S25: (A) MS/MS spectra of apigenin glucoside and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S26: (A) MS/MS spectra of taxifolin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S27: (A) MS/MS spectra of vanillin and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S28: (A) MS/MS spectra of pinoresinol and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S29: (A) MS/MS spectra of acetoxypinoresinol and its fragment ions. (B) Theoretical and experimental isotopic profiles, Figure S30: (A) MS/MS spectra of benzyl primaveroside and its fragment ions. (B) Theoretical and experimental isotopic profiles.

Author Contributions

R.C.R.: conceptualization, validation, formal analysis, investigation, and writing—original draft. L.A.: formal analysis and investigation. N.P.R. and S.J.B.: conceptualization and investigation. L.D.F.M.: conceptualization, resources, writing—review and editing, and supervision. I.C.K.-G.: conceptualization, writing—review and editing, and supervision. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior), which provided a scholarship to the first author. Additionally, financial support was received from FAPERGS (Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul), FINEP (Financiadora de Estudos e Projetos), CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), and the Programa Catalisa ICT (SEBRAE/MCTI).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data supporting the findings of this study are presented in the article and in the Supplementary Materials. Additional information can be requested by contacting the researcher Roberta Riéffel at the e-mail address: roberta.rieffel@ufrgs.br.

Acknowledgments

The authors gratefully acknowledge CAPES for the first author’s scholarship and FAPERGS, FINEP, CNPq, and Programa Catalisa ICT (SEBRAE/MCTI) for the financial support.

Conflicts of Interest

L.A. and N.P.R. declare the absence of conflicts of interest. R.C.R., S.J.B., L.D.F.M. and I.C.K.-G. have a pending patent related to this work.

Abbreviations

The following abbreviations are used in this manuscript:
SCStratum corneum
ROSReactive oxygen species
TEWLTransepidermal water loss
OPEOlive pomace extract
OLEOleuropein
HTHydroxytyrosol
iNOSInducible nitric oxide synthase
COX-2Cyclooxygenase-2
Ki-67Ki-67 antigen
NF-κBNuclear factor kappa-light-chain-enhancer of activated B cells
Nrf2Nuclear factor erythroid 2-related factor 2
PPAR- γPeroxisome proliferator-activated receptor gamma
IFN-γInterferon gamma
FTA
FOPE3
FV
Cosmetic formulation containing tocopheryl acetate
Cosmetic formulation containing OPE3
Cosmetic formulation vehicle

References

  1. Suzuki, A.; Nomura, T.; Jokura, H.; Kitamura, N.; Fujii, A.; Hase, T. Beneficial effects of oral supplementation with ferulic acid, a plant phenolic compound, on the human skin barrier in healthy men. Int. J. Vitam. Nutr. Res. 2021, 93, 4–60. [Google Scholar] [CrossRef]
  2. Liu, G.-T.; Li, Y.-L.; Wang, J.; Dong, C.-Z.; Deng, M.; Tai, M.; Deng, L.; Che, B.; Lin, L.; Du, Z.-Y.; et al. Improvement of Skin Barrier Dysfunction by Phenolic-containing Extracts of Lycium barbarum via Nrf2/HO-1 Regulation. Photochem. Photobiol. 2022, 98, 262–272. [Google Scholar] [CrossRef] [PubMed]
  3. Boo, Y.C. Can plant phenolic compounds protect the skin from airborne particulate matter? Antioxidants 2019, 8, 379. [Google Scholar] [CrossRef] [PubMed]
  4. Yoo, H.G.; Lee, B.H.; Kim, W.; Lee, J.S.; Kim, G.H.; Chun, O.K.; Koo, S.I.; Kim, D.O. Lithospermum erythrorhizon extract protects keratinocytes and fibroblasts against oxidative stress. J. Med. Food 2014, 17, 1189–1196. [Google Scholar] [CrossRef] [PubMed]
  5. Butkeviciute, A.; Ramanauskiene, K.; Kurapkiene, V.; Janulis, V. Dermal penetration studies of potential phenolic compounds ex vivo and their antioxidant activity in vitro. Plants 2022, 11, 1901. [Google Scholar] [CrossRef] [PubMed]
  6. Działo, M.; Mierziak, J.; Korzun, U.; Preisner, M.; Szopa, J.; Kulma, A. The potential of plant phenolics in prevention and therapy of skin disorders. Int. J. Mol. Sci. 2016, 17, 160. [Google Scholar] [CrossRef] [PubMed]
  7. Cai, H.; Xie, Z.; Liu, G.; Sun, X.; Peng, G.; Lin, B.; Liao, Q. Isolation, identification and activities of natural antioxidants from Callicarpa kwangtungensis Chun. PLoS ONE 2014, 9, 93000. [Google Scholar] [CrossRef] [PubMed]
  8. Nisa, R.U.; Nisa, A.U.; Tantray, A.Y.; Shah, A.H.; Jan, A.T.; Shah, A.A.; Wani, I.A. Plant phenolics with promising therapeutic applications against skin disorders: A mechanistic review. J. Agric. Food Res. 2024, 101090. [Google Scholar] [CrossRef]
  9. Gomez-Molina, M.; Albaladejo-Marico, L.; Yepes-Molina, L.; Nicolas-Espinosa, J.; Navarro-León, E.; Garcia-Ibañez, P.; Carvajal, M. Exploring phenolic compounds in crop byproducts for cosmetic efficacy. Int. J. Mol. Sci. 2024, 25, 5884. [Google Scholar] [CrossRef] [PubMed]
  10. Donner, M.; Radić, I. Innovative circular business models in the olive oil sector for sustainable mediterranean agrifood systems. Sustainability 2021, 13, 2588. [Google Scholar] [CrossRef]
  11. Nicodemou, A.; Kallis, M.; Koutinas, M. Biorefinery development for the production of polyphenols, algal biomass and lipids using olive processing industry waste. Sustain. Chem. Pharm. 2023, 32, 100998. [Google Scholar] [CrossRef]
  12. Rodrigues, F.; Pimentel, F.B.; Oliveira, M.B.P. Olive byproducts: Challenge application in cosmetic industry. Ind. Crops Prod. 2015, 70, 116–124. [Google Scholar] [CrossRef]
  13. Ramírez, I.M.; Vaz, D.A.; Banat, I.M.; Marchant, R.; Alameda, E.J.; Román, M.G. Hydrolysis of olive mill waste to enhance rhamnolipids and surfactin production. Bioresour. Technol. 2016, 205, 1–6. [Google Scholar] [CrossRef] [PubMed]
  14. Contreras, M.; Romero, I.; Moya, M.; Castro, E. Olive-derived biomass as a renewable source of value-added products. Process Biochem. 2020, 97, 43–56. [Google Scholar] [CrossRef]
  15. Servili, M.; Esposto, S.; Taticchi, A.; Urbani, S.; Di Maio, I.; Veneziani, G.; Selvaggini, R. New approaches to virgin olive oil quality, technology, and by-products valorization. Eur. J. Lipid Sci. Technol. 2015, 117, 1882–1892. [Google Scholar] [CrossRef]
  16. Annab, H.; Fiol, N.; Villaescusa, I.; Essamri, A. A proposal for the sustainable treatment and valorization of olive mill wastes. J. Environ. Chem. Eng. 2019, 7, 102803. [Google Scholar] [CrossRef]
  17. Ruesgas-Ramón, M.; Figueroa-Espinoza, M.C.; Durand, E. Application of deep eutectic solvents (DES) for phenolic compounds extraction: Overview, challenges, and opportunities. J. Agric. Food Chem. 2017, 65, 3591–3601. [Google Scholar] [CrossRef] [PubMed]
  18. Katsinas, N.; Bento da Silva, A.; Enríquez-de-Salamanca, A.; Fernández, N.; Bronze, M.R.; Rodríguez-Rojo, S. Pressurized liquid extraction optimization from supercritical defatted olive pomace: A green and selective phenolic extraction process. ACS Sustain. Chem. Eng. 2021, 9, 5590–5602. [Google Scholar] [CrossRef]
  19. Faria-Silva, A.C.; Mota, A.L.; Costa, A.M.; Silva, A.M.; Ascenso, A.; Reis, C.; Marto, J.; Ribeiro, H.M.; Cavalheiro, M.; Simões, S. Application of natural raw materials for development of cosmetics through nanotechnology. In Nanotechnology for the Preparation of Cosmetics Using Plant-Based Extracts; Elsevier: Amsterdam, The Netherlands, 2022; pp. 157–201. [Google Scholar] [CrossRef]
  20. Pinto, J.R.; Monteiro e Silva, S.A.; Leonardi, G.R. Effects of 1, 3-propanediol associated, or not, with butylene glycol and/or glycerol on skin hydration and skin barrier function. Int. J. Cosm. Sci. 2024, 46, 85–95. [Google Scholar] [CrossRef] [PubMed]
  21. Hordyjewicz-Baran, Z.; Wasilewski, T.; Zarębska, M.; Stanek-Wandzel, N.; Zajszły-Turko, E.; Tomaka, M.; Zagórska-Dziok, M. Micellar and Solvent Loan Chemical Extraction as a Tool for the Development of Natural Skin Care Cosmetics Containing Substances Isolated from Grapevine Buds. Appl. Sci. 2024, 14, 1420. [Google Scholar] [CrossRef]
  22. Cadiz-Gurrea, M.D.L.L.; Pinto, D.; Delerue-Matos, C.; Rodrigues, F. Olive fruit and leaf wastes as bioactive ingredients for cosmetics—A preliminary study. Antioxidants 2021, 10, 245. [Google Scholar] [CrossRef] [PubMed]
  23. Kishikawa, A.; Ashour, A.; Zhu, Q.; Yasuda, M.; Ishikawa, H.; Shimizu, K. Multiple biological effects of olive oil by-products such as leaves, stems, flowers, olive milled waste, fruit pulp, and seeds of the olive plant on skin. Phytother. Res. 2015, 29, 877–886. [Google Scholar] [CrossRef] [PubMed]
  24. Rodrigues, R.; Alves, R.C.; Oliveira, M.B.P. Exploring olive pomace for skincare applications: A review. Cosmetics 2023, 10, 35. [Google Scholar] [CrossRef]
  25. UN. United Nations. Sustainable Development Goals. Goal 12: Ensure Sustainable Consumption and Production. Available online: https://www.unep.org/topics/sustainable-development-goals/why-do-sustainable-development-goals-matter/goal-12-9 (accessed on 11 October 2024).
  26. Waterhouse, A.L. Determination of Total Phenolics. In Current Protocols in Food Analytical Chemistry; Wrolstad, R.E., Ed.; John Wiley & Sons: New York, NY, USA, 2002; pp. I1.1.1–I1.1.8. [Google Scholar] [CrossRef]
  27. Chang, C.C.; Yang, M.H.; Wen, H.M.; Chern, J.C. Estimation of total flavonoid content in propolis by two complementary colorimetric methods. J. Food Drug Anal. 2002, 10, 178–182. [Google Scholar] [CrossRef]
  28. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef] [PubMed]
  29. Gonzales, M.; Villena, G.K.; Kitazono, A.A. Evaluation of the antioxidant activities of aqueous extracts from seven wild plants from the Andes using an in vivo yeast assay. Results Chem. 2021, 3, 100098. [Google Scholar] [CrossRef]
  30. Paim, L.F.N.A.; Dalla Lana, D.F.; Giaretta, M.; Danielli, L.J.; Fuentefria, A.M.; Apel, M.A.; Külkamp-Guerreiro, I.C. Poiretia latifolia essential oil as a promising antifungal and anti-inflammatory agent: Chemical composition, biological screening, and development of a nanoemulsion formulation. Ind. Crops Prod. 2018, 126, 280–286. [Google Scholar] [CrossRef]
  31. Kesente, M.; Kavetsou, E.; Roussaki, M.; Blidi, S.; Loupassaki, S.; Chanioti, S.; Siamandoura, P.; Stamatogianni, C.; Philippou, E.; Papaspyrides, C.; et al. Encapsulation of olive leaves extracts in biodegradable PLA nanoparticles for use in cosmetic formulation. Bioengineering. 2017, 4, 75. [Google Scholar] [CrossRef] [PubMed]
  32. Habibi, H.; Mohammadi, A.; Farhoodi, M.; Jazaeri, S. Application and optimization of microwave-assisted extraction and dispersive liquid–liquid microextraction followed by high-performance liquid chromatography for the determination of oleuropein and hydroxytyrosol in olive pomace. Food Anal. Method. 2018, 11, 3078–3088. [Google Scholar] [CrossRef]
  33. Peralbo-Molina, A.; Priego-Capote, F.; Luque de Castro, M.D. Tentative identification of phenolic compounds in olive pomace extracts using liquid chromatography–tandem mass spectrometry with a quadrupole–quadrupole-time-of-flight mass detector. J. Agric. Food Chem. 2012, 60, 11542–11550. [Google Scholar] [CrossRef] [PubMed]
  34. Shen, Y.; Xu, Z.; Sheng, Z. Ability of resveratrol to inhibit advanced glycation end product formation and carbohydrate-hydrolyzing enzyme activity, and to conjugate methylglyoxal. Food Chem. 2017, 216, 153–160. [Google Scholar] [CrossRef] [PubMed]
  35. Perazzo, A.; Preziosi, V.; Guido, S. Phase inversion emulsification: Current understanding and applications. Adv. Colloid Interface Sci. 2015, 222, 581–599. [Google Scholar] [CrossRef] [PubMed]
  36. Anastas, P.; Eghbali, N. Green chemistry: Principles and practice. Chem. Soc. Rev. 2010, 39, 301–312. [Google Scholar] [CrossRef] [PubMed]
  37. Goldsmith, C.D.; Bond, D.R.; Jankowski, H.; Weidenhofer, J.; Stathopoulos, C.E.; Roach, P.D.; Scarlett, C.J. The olive biophenols oleuropein and hydroxytyrosol selectively reduce proliferation, influence the cell cycle, and induce apoptosis in pancreatic cancer cells. Int. J. Mol. Sci. 2018, 19, 1937. [Google Scholar] [CrossRef] [PubMed]
  38. Vaou, N.; Voidarou, C.; Rozos, G.; Saldari, C.; Stavropoulou, E.; Vrioni, G.; Tsakris, A. Unraveling Nature’s Pharmacy: Transforming Medicinal Plants into Modern Therapeutic Agents. Pharmaceutics 2025, 17, 754. [Google Scholar] [CrossRef] [PubMed]
  39. Almeida Pontes, P.V.; Czaikoski, A.; Almeida, N.A.; Fraga, S.; de Oliveira Rocha, L.; Cunha, R.L.; Maximo, G.J.; Batista, E.A.C. Extraction optimization, biological activities, and application in O/W emulsion of deep eutectic solvents-based phenolic extracts from olive pomace. Food Res. Int. 2022, 161, 111753. [Google Scholar] [CrossRef] [PubMed]
  40. Chanioti, S.; Tzia, C. Extraction of phenolic compounds from olive pomace by using natural deep eutectic solvents and innovative extraction techniques. Innov. Food Sci. Emerg. Technol. 2018, 48, 228–239. [Google Scholar] [CrossRef]
  41. Bradic, J.; Petrovic, A.; Kocovic, A.; Ugrinovic, V.; Popovic, S.; Ciric, A.; Markovic, Z.; Avdovic, E. Development and Optimization of Gelatin-Alginate Hydrogels Loaded with Grape Skin Extract: Evaluation of Antioxidant and Antimicrobial Properties. Pharmaceutics 2025, 17, 790. [Google Scholar] [CrossRef] [PubMed]
  42. Carrara, M.; Kelly, M.T.; Roso, F.; Larroque, M.; Margout, D. Potential of olive oil mill wastewater as a source of polyphenols for the treatment of skin disorders: A review. J. Agric. Food Chem. 2021, 69, 7268–7284. [Google Scholar] [CrossRef] [PubMed]
  43. Nunes, M.A.; Costa, A.S.; Bessada, S.; Santos, J.; Puga, H.; Alves, R.C.; Freitas, V.; Oliveira, M.B.P. Olive pomace as a valuable source of bioactive compounds: A study regarding its lipid-and water-soluble components. Sci. Total Environ. 2018, 644, 229–236. [Google Scholar] [CrossRef] [PubMed]
  44. Karaosmanoglu, H.; Soyer, F.; Ozen, B.; Tokatli, F. Antimicrobial and antioxidant activities of Turkish extra virgin olive oils. J. Agric. Food Chem. 2010, 58, 8238–8245. [Google Scholar] [CrossRef] [PubMed]
  45. Schwenke, D.C.; Behr, S.R. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations. Circ. Res. 1998, 83, 366–377. [Google Scholar] [CrossRef] [PubMed]
  46. Huang, D.; Ou, B.; Prior, R.L. The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 2005, 53, 1841–1856. [Google Scholar] [CrossRef]
  47. Iwasaki, T.; Uchiyama, R.; Nosaka, K. Difference in Antimicrobial Activity of Propan-1,3-diol and Propylene Glycol. Chem. Pharm. Bull. 2023, 71, 74–77. [Google Scholar] [CrossRef] [PubMed]
  48. Smeriglio, A.; Denaro, M.; Mastracci, L.; Grillo, F.; Cornara, L.; Shirooie, S.; Mohammad, N.; Trombetta, D. Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: In vitro evaluation on reconstructed human epidermis model. DARU J. Pharm. Sci. 2019, 27, 283–293. [Google Scholar] [CrossRef] [PubMed]
  49. Özcan, M.M.; Matthäus, B. A review: Benefit and bioactive properties of olive (Olea europaea L.) leaves. Eur. Food Res.Technol. 2017, 243, 89–99. [Google Scholar] [CrossRef]
  50. Nediani, C.; Ruzzolini, J.; Romani, A.; Calorini, L. Oleuropein, a bioactive compound from Olea europaea L., as a potential preventive and therapeutic agent in noncommunicable diseases. Antioxidants 2019, 8, 578. [Google Scholar] [CrossRef] [PubMed]
  51. Asghariazar, V.; Vahidian, F.; Karimi, A.; Abbaspour-Ravasjani, S.; Mansoori, B.; Safarzadeh, E. The Role of Oleuropein, Derived from Olives, in Human Skin Fibroblast Cells: Investigating the Underlying Molecular Mechanisms of Cytotoxicity and Antioxidant and Anti-Inflammatory Activities. Int. J. Clin. Pract. 2024, 1, 8827501. [Google Scholar] [CrossRef]
  52. Quirantes-Piné, R.; Zurek, G.; Barrajón-Catalán, E.; Bäßmann, C.; Micol, V.; Segura-Carretero, A.; Fernández-Gutiérrez, A. A metabolite-profiling approach to assess the uptake and metabolism of phenolic compounds from olive leaves in SKBR3 cells by HPLC–ESI-QTOF-MS. J. Pharm. Biomed. Anal. 2013, 72, 121–126. [Google Scholar] [CrossRef] [PubMed]
  53. Serrano-García, I.; Olmo-García, L.; Polo-Megías, D.; Serrano, A.; León, L.; de la Rosa, R.; Carrasco-Pancorbo, A. Fruit Phenolic and triterpenic composition of progenies of Olea europaea subsp. cuspidata, an interesting phytochemical source to be included in olive breeding programs. Plants 2022, 11, 1791. [Google Scholar] [CrossRef]
  54. Klen, T.J.; Vodopivec, B.M. The fate of olive fruit phenols during commercial olive oil processing: Traditional press versus continuous two-and three-phase centrifuge. LWT-Food Sci. Technol. 2012, 49, 267–274. [Google Scholar] [CrossRef]
  55. D’Antuono, I.; Garbetta, A.; Ciasca, B.; Linsalata, V.; Minervini, F.; Lattanzio, V.M.; Logrieco, A.F.; Cardinali, A. Biophenols from table olive cv Bella di Cerignola: Chemical characterization, bioaccessibility, and intestinal absorption. J. Agric. Food Chem. 2016, 64, 5671–5678. [Google Scholar] [CrossRef] [PubMed]
  56. Emma, M.R.; Augello, G.; Di Stefano, V.; Azzolina, A.; Giannitrapani, L.; Montalto, G.; Cervello, M.; Cusimano, A. Potential uses of olive oil secoiridoids for the prevention and treatment of cancer: A narrative review of preclinical studies. Int. J. Mol. Sci. 2021, 22, 1234. [Google Scholar] [CrossRef] [PubMed]
  57. Kalogiouri, N.P.; Kritikou, E.; Martakos, I.C.; Lazarou, C.; Pentogennis, M.; Thomaidis, N.S. Characterization of the Phenolic Fingerprint of Kolovi Extra Virgin Olive Oils from Lesvos with Regard to Altitude and Farming System Analyzed by UHPLC–QTOF–MS. Molecules 2021, 26, 5634. [Google Scholar] [CrossRef] [PubMed]
  58. Abbattista, R.; Ventura, G.; Calvano, C.D.; Cataldi, T.R.; Losito, I. Bioactive compounds in waste byproducts from olive oil production: Applications and structural characterization by mass spectrometry techniques. Foods 2021, 10, 1236. [Google Scholar] [CrossRef] [PubMed]
  59. Owen, R.W.; Giacosa, A.; Hull, W.E.; Haubner, R.; Würtele, G.; Spiegelhalder, B.; Bartsch, H. Olive-oil consumption and health: The possible role of antioxidants. Lancet Oncol. 2000, 1, 107–112. [Google Scholar] [CrossRef] [PubMed]
  60. Benincasa, C.; Pellegrino, M.; Veltri, L.; Claps, S.; Fallara, C.; Perri, E. Dried destoned virgin olive pomace: A promising new byproduct from pomace extraction process. Molecules 2021, 26, 4337. [Google Scholar] [CrossRef] [PubMed]
  61. Márquez, K.; Márquez, N.; Ávila, F.; Cruz, N.; Burgos-Edwards, A.; Pardo, X.; Carrasco, B. Oleuropein-Enriched Extract from Olive Mill Leaves by Homogenizer-Assisted Extraction and Its Antioxidant and Antiglycating Activities. Front. Nutr. 2022, 9, 895070. [Google Scholar] [CrossRef] [PubMed]
  62. Kontogianni, V.G.; Charisiadis, P.; Margianni, E.; Lamari, F.N.; Gerothanassis, I.P.; Tzakos, A.G. Olive leaf extracts are a natural source of advanced glycation end product inhibitors. J. Med. Food 2013, 16, 817–822. [Google Scholar] [CrossRef] [PubMed]
  63. Ramkissoon, J.S.; Mahomoodally, M.F.; Ahmed, N.; Subratty, A.H. Antioxidant and anti–glycation activities correlates with phenolic composition of tropical medicinal herbs. Asian Pac. J. Trop. Med. 2013, 6, 561–569. [Google Scholar] [CrossRef] [PubMed]
  64. Kabach, I.; Bouchmaa, N.; Ben Mrid, R.; Zouaoui, Z.; Maadoudi, M.E.; Kounnoun, A.; Asraoui, F.; Mansouri, F.E.; Zyad, A.; Cacciola, F.; et al. Olea europaea var. Oleaster a promising nutritional food with in vitro antioxidant, antiglycation, antidiabetic and antiproliferative effects. J. Food Meas. Charact. 2023, 17, 882–894. [Google Scholar] [CrossRef]
  65. Wang, L.; Jiang, Y.; Zhao, C. The effects of advanced glycation end-products on skin and potential anti-glycation strategies. Exp. Dermatol. 2024, 33, 15065. [Google Scholar] [CrossRef] [PubMed]
  66. Almeida, M.M.D.; Lima, C.R.R.D.C.; Quenca-Guillen, J.S.; Moscardini Filho, E.; Mercuri, L.P.; Santoro, M.I.R.M.; Kedor-Hackmann, E.R.M. Stability evaluation of tocopheryl acetate and ascorbyl tetraisopalmitate in isolation and incorporated in cosmetic formulations using thermal analysis. Braz. J. Pharm. Sci. 2010, 46, 129–134. [Google Scholar] [CrossRef]
Figure 1. The results of the analysis of antioxidant activity are expressed as the percentage of ABTS radical inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Figure 1. The results of the analysis of antioxidant activity are expressed as the percentage of ABTS radical inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g001
Figure 2. The results of the analysis of antioxidant activity are expressed as the percentage of DPPH radical inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Figure 2. The results of the analysis of antioxidant activity are expressed as the percentage of DPPH radical inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g002
Figure 3. The results are expressed as the percentage of oxidation inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Figure 3. The results are expressed as the percentage of oxidation inhibition. Different letters (a, b and c) indicate significant differences between samples. The same letters within the same concentration do not differ. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g003
Figure 4. Analysis of the stability of olive pomace extracts (expressed as percentages of Folin–Ciocalteu reducing capacity). Different letters (a and b) indicate significant differences between samples. Different letters indicate significant differences. The data were analyzed via one-way ANOVA and Dunnett’s post hoc test (p < 0.05).
Figure 4. Analysis of the stability of olive pomace extracts (expressed as percentages of Folin–Ciocalteu reducing capacity). Different letters (a and b) indicate significant differences between samples. Different letters indicate significant differences. The data were analyzed via one-way ANOVA and Dunnett’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g004
Figure 5. Determination of hydroxytyrosol (HT) and oleuropein (OLE) contents in olive pomace extracts. The results are presented as µg/mL in the extract. Different letters (a, b and c) in each compound analysis indicate significant differences. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Figure 5. Determination of hydroxytyrosol (HT) and oleuropein (OLE) contents in olive pomace extracts. The results are presented as µg/mL in the extract. Different letters (a, b and c) in each compound analysis indicate significant differences. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g005
Figure 6. (A) MS/MS spectra of OPE3 and hydroxytyrosol; (B) hydroxytyrosol and its fragments; (C) theoretical and experimental isotopic profiles.
Figure 6. (A) MS/MS spectra of OPE3 and hydroxytyrosol; (B) hydroxytyrosol and its fragments; (C) theoretical and experimental isotopic profiles.
Pharmaceutics 17 00962 g006
Figure 7. (A) MS/MS spectra of oleoside and OPE3; (B) oleoside and its fragments; (C) theoretical and experimental isotopic profiles.
Figure 7. (A) MS/MS spectra of oleoside and OPE3; (B) oleoside and its fragments; (C) theoretical and experimental isotopic profiles.
Pharmaceutics 17 00962 g007
Figure 8. (A) MS/MS spectra of oleuropein and OPE3; (B) oleuropein and its fragments; (C) theoretical and experimental isotopic profiles.
Figure 8. (A) MS/MS spectra of oleuropein and OPE3; (B) oleuropein and its fragments; (C) theoretical and experimental isotopic profiles.
Pharmaceutics 17 00962 g008
Figure 9. The results of the analysis of antioxidant activity are expressed as the percentage of DPPH radical inhibition. FOPE3: cosmetic formulation containing OPE3; FTA: cosmetic formulation containing tocopheryl acetate; FV: vehicle formulation. Different letters (a, b and c) indicate significant differences. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Figure 9. The results of the analysis of antioxidant activity are expressed as the percentage of DPPH radical inhibition. FOPE3: cosmetic formulation containing OPE3; FTA: cosmetic formulation containing tocopheryl acetate; FV: vehicle formulation. Different letters (a, b and c) indicate significant differences. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Pharmaceutics 17 00962 g009
Table 1. Composition of the cosmetic emulsion formulation.
Table 1. Composition of the cosmetic emulsion formulation.
ComponentConcentration (%)Function
Potassium cetyl phosphate0.5emulsifier, surfactant
Cetearyl olivate (and) sorbitan olivate1.0emulsifier, stabilizer
Caprylic/Capric triglycerides5.0emollient
Lonicera japonica flower extract and Lonicera caprifolium flower extract1.0preservative
Ultrapure water92.5vehicle
Table 2. Characterization of OPE: reducing capacity of the Folin–Ciocalteu reagent and total flavonoid content.
Table 2. Characterization of OPE: reducing capacity of the Folin–Ciocalteu reagent and total flavonoid content.
ExtractsReducing Capacity
(mg GAE/g)
Total Flavonoid
(mg QE/g)
OPE114.9 ± 0.5 b4.0 ± 0.7 c
OPE229.0 ± 1.3 a5.0 ± 0.2 b
OPE333.0 ± 5.7 a5.3 ± 0.2 a
The values are expressed as the means ± standard deviations. Different letters (a, b and c) indicate significant differences between samples. The same letters within a column indicate the absence of a significant difference. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Table 3. ABTS radical inhibition capacity.
Table 3. ABTS radical inhibition capacity.
AntioxidantIC50 (mg/mL)
Butyl hydroxytoluene (BHT)0.024 ± 0.02 e
Tocopheryl acetate183 ± 0.6 a
OPE119 ± 0.02 b
OPE216 ± 0.02 c
OPE311 ± 0.01 d
The results are expressed as the IC50, which was calculated as the ability to reduce the sample absorbance by 50%. Different letters (a, b, c, d, and e) indicate significant differences between samples. The same letters do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Table 4. DPPH radical inhibition capacity.
Table 4. DPPH radical inhibition capacity.
AntioxidantIC50 (mg/mL)
Butyl hydroxytoluene (BHT)0.1 ± 0.00 c
Tocopheryl acetate49.1 ± 1.04 a
OPE34.4 ± 0.08 b
The results are expressed as the IC50, which was calculated as the ability to reduce the sample absorbance by 50%. Different letters (a, b and c) indicate significant differences between samples. The same letters do not differ significantly. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Table 5. Compounds in OPE3 identified by UHPLC-QqTOF-MS.
Table 5. Compounds in OPE3 identified by UHPLC-QqTOF-MS.
Compounds
(Molecular Formula)
ErrormSigma *TRm/z theom/z expFragments
Hydroxytyrosol
C8H10O3
−1.4 5.6 1.7 153.0559 153.0557 123.0405
105.0339
135.0451
123.0000
135.0000
Tyrosol
C8H10O2
2.2 n.a. 5.6 137.0611 137.0608 119.0505
137.0603
Dihydroxytyrosol
C14H20O8
0.3 6.9 0.9 315.1086 315.1085 151.0397
123.0448
151.0398
Tyrosol glucoside
C14H20O7
−0.3 15.0 2.3 299.1135 299.1136 119.0505
299.1139
119.0349
101.0244
089.0245
Hydroxytyrosol glucoside
C14H20O8
−0.3 2.1 1.8 315.1085 315.1085 315.1074
123.0446
153.0570
Loganin
C17H26O10
−0.4 20.8 2.1 389.1452 389.1453 151.0776
113.0348
101.0206
228.0902
Secologanin
C17H24O10
0.0 19.2 2.8 387.1297 387.1297 147.0443
Loganic acid
C16H24O10
0.6 7.8 2.0 375.1299 375.1297 107.0506
101.0245
213.0000
113.0248
Secologanoside
C16H22O11
−0.1 5.6 5.5 555.1719 555.1719 059.0139
089.0234
Comselogoside
C25H28O13
0.5 3.3 7.7 535.1460 535.1457 491.1558
345.1197
145.0296
535.0000
Caffeoyl-6′-secologanoside
C25H28O14
−0.8 10.5 6.9 551.1411 551.1406 507.1504
345.1193
281.0673
161.0245
Oleoside
C16H22O11
−1.1 1.8 3.1 389.1094 389.1089 121.0660
101.0243
209.0477
345.1253
Oleoside dimethylester
C18H26O11
0.1 4.5 3.2 417.1402 417.1402 185.0000
101.0000
244.0000
Oleoside glucoside
C22H32O16
−0.2 31.6 3.2 551.1617 551.1618 551.1707
507.1805
209.0480
Oleoside riboside
C20H26O15
0.8 27.8 4.0 505.1203 505.1199 389.1166
505.1298
345.1256
Oleoside dimethylester
C18H26O11
0.1 4.5 3.2 417.1402 417.1402 185.0000
101.0000
244.0000
Luteolin
C21H20O10
−1.1 23.5 6.9 431.0989 431.0984 431.0973
255.0295
284.0276
Luteolin glucoside
C21H20O11
0.1 5.3 6.2 447.0933 447.0933 285.0423
Taxifolin
C15H12O7
−0.7 15.9 6.6 303.0512 303.0510 179.0000
255.1114
Rutin
C27H30O16
−0.2 7.6 6.0 609.1462 609.1461 300.0274
497.0000
Vanillin
C8H8O3
1.6 5.6 1.8 151.0403 151.0401 151.0397
105.0341
135.9000
Benzyl b-primeveroside
C18H26O10
0.0 20.3 3.5 401.1453 401.1453 223.0000
Oleuropein
C25H32O13
0.0 6.2 7.4 539.1770 539.1770 539.1759
377.1306
307.0874
275.0962
Oleuropein aglycone
C19H22O8
−0.2 2.4 10.5 377.1243 377.1242 111.0088
149.0244
195.0645
275.0913
307.0823
Luteolin glucoside
C21H20O11
0.1 5.3 6.2 447.0933 447.0933 285.0423
Dihydro-oleuropein
C25H36O13
−0.5 34.6 6.3 543.2086 543.2083 377.1522
Oleuropein diglucoside
C25H36O12
0.0 8.3 7.2 527.2134 527.2134 377.1481
10-hydroxy-oleuropein
C25H32O14
−0.1 5.6 5.5 555.1719 555.1719 537.1647
376.1114
Oleacein
C17H20O6
0.6 17.4 8.5 319.1187 319.1187 139.0602
165.0556
183.0660
Acetoxypinoresinol
C22H24O8
−0.8 23.5 9.2 415.1395 415.1398 280.0951
343.1188
Apigenin glucoside
C21H20O10
1.1 23.5 6.9 431.0989 431.0984 269.0446
240.0462
p-HPEA-EA
C19H22O7
−0.2 2.4 12.1 361.1294 361.1293 361.0000
139.0000
Pinoresinol
C20H22O6
0.9 17.9 7.8 357.1347 357.1344 311.1363
175.0787
85.9461
214.3294
Verbascoside
C29H36O15
−0.8 7.7 6.1 623.1986 623.1981 461.1744
161.0254
161.0000
* mSigma values < 50 indicate a high probability of a correct formula. TR = retention time.
Table 6. Antiglycation capacity.
Table 6. Antiglycation capacity.
ExtractsConcentration
(mg/mL)
Antiglycation Capacity
(%)
OPE32.024.4 ± 3.2 c
OPE33.540.4 ± 3.1 b
Carnosine0.391.0 ± 3.4 a
The values are expressed as the means ± standard deviations. Different letters within a column indicate different results. The data were analyzed via one-way ANOVA and Tukey’s post hoc test (p < 0.05).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Riéffel, R.C.; Agostini, L.; Rodrigues, N.P.; Berlitz, S.J.; Marczak, L.D.F.; Külkamp-Guerreiro, I.C. Sustainable Olive Pomace Extracts for Skin Barrier Support. Pharmaceutics 2025, 17, 962. https://doi.org/10.3390/pharmaceutics17080962

AMA Style

Riéffel RC, Agostini L, Rodrigues NP, Berlitz SJ, Marczak LDF, Külkamp-Guerreiro IC. Sustainable Olive Pomace Extracts for Skin Barrier Support. Pharmaceutics. 2025; 17(8):962. https://doi.org/10.3390/pharmaceutics17080962

Chicago/Turabian Style

Riéffel, Roberta Cougo, Lucas Agostini, Naira Poener Rodrigues, Simone Jacobus Berlitz, Lígia Damasceno Ferreira Marczak, and Irene Clemes Külkamp-Guerreiro. 2025. "Sustainable Olive Pomace Extracts for Skin Barrier Support" Pharmaceutics 17, no. 8: 962. https://doi.org/10.3390/pharmaceutics17080962

APA Style

Riéffel, R. C., Agostini, L., Rodrigues, N. P., Berlitz, S. J., Marczak, L. D. F., & Külkamp-Guerreiro, I. C. (2025). Sustainable Olive Pomace Extracts for Skin Barrier Support. Pharmaceutics, 17(8), 962. https://doi.org/10.3390/pharmaceutics17080962

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop